First Trust Eurozone AlphaDEX ETF (FEUZ)
Live price chart, market sentiment, and community perspectives for First Trust Eurozone AlphaDEX ETF (NASDAQ: FEUZ).
Live price chart, market sentiment, and community perspectives for First Trust Eurozone AlphaDEX ETF (NASDAQ: FEUZ).
Dealer gamma exposure on FEUZ creates elevated volatility near the current strike cluster. Not adding exposure until after the backlog data clears.
On our desk, we've been tracking FEUZ's market sentiment closely. The fund trades at a price of $68.48 with a very low floating short interest of just 0.41% as of July 2026, indicating minimal immediate bearish conviction from short sellers. However, investors need to be cognizant of its structural positioning: it runs a very aggressive Morningstar risk score of 86, placing it in the highest-risk tier. While it delivered a strong 1-year NAV return of 26.6% outperforming the Europe Stock average, its market sentiment is heavily tied to how well its momentum and value tilts handle macro swings.
Reviewing the risk metrics for FEUZ reveals a distinct pattern of amplified volatility. The fund's 5Y and 10Y standard deviations sit around 18.7% to 18.9%, comfortably above the category average of 17.2%. Furthermore, its 10Y beta of 1.17 confirms that it takes on structurally more market risk than a typical Europe Stock peer. Downside capture ratios ranging between 117 and 122 illustrate that the fund aggressively compounds losses during market downturns, hitting worst drawdowns of -37.2% compared to the category's -30.9%.
When analyzing the execution protocols of quantitative factor ETFs like FEUZ, turnover is a critical parameter to stress test. FEUZ registers a striking 91% portfolio turnover rate, towering over the 30% average seen across the broader Europe Stock category. From a strategic modeling perspective, this high churn means analysts must factor in potential friction regarding expenses and after-tax efficiency, especially given its historical tax-cost ratios hovering around 0.8% to 1.0%.
Explore plasma cleansing, somatic organ swaps, and BCI.